AP2550A - Method for converting aloeresin a to aloesin - Google Patents

Method for converting aloeresin a to aloesin

Info

Publication number
AP2550A
AP2550A AP2007004199A AP2007004199A AP2550A AP 2550 A AP2550 A AP 2550A AP 2007004199 A AP2007004199 A AP 2007004199A AP 2007004199 A AP2007004199 A AP 2007004199A AP 2550 A AP2550 A AP 2550A
Authority
AP
ARIPO
Prior art keywords
aloesin
aloeresin
converting
converting aloeresin
Prior art date
Application number
AP2007004199A
Other languages
English (en)
Other versions
AP2007004199A0 (en
Inventor
Lucia Hendrina Steenkamp
Robin Kumar Mitra
Steven James Heggie
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of AP2007004199A0 publication Critical patent/AP2007004199A0/xx
Application granted granted Critical
Publication of AP2550A publication Critical patent/AP2550A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2007004199A 2005-03-18 2006-03-13 Method for converting aloeresin a to aloesin AP2550A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA200502308 2005-03-18
ZA200502310 2005-03-18
PCT/IB2006/000542 WO2006097811A1 (en) 2005-03-18 2006-03-13 Method for converting aloeresin a to aloesin

Publications (2)

Publication Number Publication Date
AP2007004199A0 AP2007004199A0 (en) 2007-10-31
AP2550A true AP2550A (en) 2012-12-31

Family

ID=36571968

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004199A AP2550A (en) 2005-03-18 2006-03-13 Method for converting aloeresin a to aloesin

Country Status (11)

Country Link
US (1) US9434710B2 (xx)
EP (1) EP1874751B1 (xx)
JP (2) JP2008533123A (xx)
KR (2) KR101555639B1 (xx)
AP (1) AP2550A (xx)
AT (1) ATE532776T1 (xx)
AU (1) AU2006224289B2 (xx)
BR (1) BRPI0608509A8 (xx)
HK (1) HK1119169A1 (xx)
RU (1) RU2397167C2 (xx)
WO (1) WO2006097811A1 (xx)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735935A (en) 1985-12-17 1988-04-05 Carrington Laboratories, Inc. Process for preparation of aloe products products, produced thereby and compositions thereof
LU85320A1 (fr) * 1984-04-17 1985-11-27 Oreal Composition cosmetique contenant de l'aloesine a titre d'agent de protection contre la lumiere solaire et son utilisation pour la protection de la peau et des cheveux
JPH0764703B2 (ja) * 1986-06-04 1995-07-12 晟 八木 チロジナ−ゼ阻碍剤
US4944953A (en) * 1989-05-19 1990-07-31 A. E. Staley Manufacturing Company Purification of hydrolysed protein with crystalline zeolite
US5652265A (en) * 1995-03-29 1997-07-29 Wisconsin Alumni Research Foundation Production of rhein and rhein derivatives
JPH08325155A (ja) * 1995-06-01 1996-12-10 Nonogawa Shoji Kk 免疫抑制改善剤
JP3733168B2 (ja) * 1996-03-08 2006-01-11 丸善製薬株式会社 バルバロインを含有する飲料およびその製造法
AU2222499A (en) * 1998-01-12 1999-07-26 Univera Pharmaceuticals, Inc. Method of synthesis of derivatives of aloesin
US6123959A (en) * 1998-04-24 2000-09-26 Univera Pharmaceuticals, Inc. Aqueous composition comprising active ingredients for the de-pigmentation of the skin
US6451357B1 (en) * 2001-02-26 2002-09-17 Unigen Pharmaceuticals, Inc. Method for purification of aloesin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
P. GRAMATICA, D. MONTI, G. SPERANZA AND P. MANITTO: "Aloe Revisited, The Structure of Aloeresin A" TETRAHEDRON LETTERS, vol. 23, no. 23, 1982, pages 2423-2424, XP002386193 � *
QING-MING CHE, TERUAKI AKAO, MASAO HATTORI, KYOICHI KOBASHI, TSUNEO NAMBA: "Metabolism of Aloesin and Related Compounds by Human Intestinal Bacteria: A Bacterial Cleavage of the C-Glucosyl Bond and the Subsequent Reduction of the Acetonyl Side Chain." CHEM. PHARM. BULL., vol. 39, no. 3, 1991, pages 704-708, XP001246851 � *

Also Published As

Publication number Publication date
HK1119169A1 (en) 2009-02-27
US20080280348A1 (en) 2008-11-13
US9434710B2 (en) 2016-09-06
KR101555639B1 (ko) 2015-09-24
AP2007004199A0 (en) 2007-10-31
BRPI0608509A2 (pt) 2010-11-16
AU2006224289B2 (en) 2013-01-24
EP1874751B1 (en) 2011-11-09
EP1874751A1 (en) 2008-01-09
KR20080034091A (ko) 2008-04-18
AU2006224289A1 (en) 2006-09-21
BRPI0608509A8 (pt) 2019-01-29
JP5763691B2 (ja) 2015-08-12
ATE532776T1 (de) 2011-11-15
KR20140010195A (ko) 2014-01-23
RU2397167C2 (ru) 2010-08-20
JP2008533123A (ja) 2008-08-21
WO2006097811A1 (en) 2006-09-21
JP2013075919A (ja) 2013-04-25
RU2007138642A (ru) 2009-04-27

Similar Documents

Publication Publication Date Title
TWI340330B (en) Method for text-to-pronunciation conversion
ZA201002186B (en) Conversion method
EP2239236A4 (en) CONCENTRATED SLUDGE WASTE PROCESSING
GB0625995D0 (en) Method for preparing a composition
EP1994124A4 (en) PROCESSES FOR CONVERTING TRICLYCERIDES TO HYDROCARBONS
EP1968917A4 (en) METHOD FOR CONVERTING CARBOHYDRATES IN HYDROCARBONS
ZA201002185B (en) Conversion method
PL1844189T3 (pl) Sposób przygotowania wymazówki
HK1139595A1 (en) A method for enhancing cell response
GB0807891D0 (en) A method for obtaining a xeno-free HBS cell line
PL2818075T3 (pl) Sposób ozdabiania przezroczystego flakonu
EP2103603A4 (en) PROCESS FOR PREPARING A PYRROLIDINE COMPOUND
ZA201001209B (en) Method for producing ²-nitrostyrene compound
GB0711313D0 (en) A method for making phenylalkylsiloxanes
EP2221306A4 (en) PROCESS FOR PREPARING 2-AZAADAMANTANE
EP1870821A4 (en) IMPLEMENTATION PROCEDURES FOR STRUCTURED DATA
GB0724491D0 (en) A method
IL208454A (en) Methods for combining a compound
EP2241606A4 (en) METHOD FOR PRODUCING A BIOMATERIAL
IL204417A0 (en) Novel method for preparing pregabalin
IL209909A (en) METHOD FOR PRODUCING 1-BIPENYLMETHYLMETHYLMIDAZOLE
HK1141010A1 (en) Method for producing 2-haloimidazole compound
GB0910726D0 (en) A method for preparing sulfur-containing compounds
IL193248A0 (en) A method for producing o-methyl-n-nitroisourea
EP2226312A4 (en) PROCESS FOR PRODUCING 3-MERCAPTOANILINE COMPOUND